Year |
Citation |
Score |
2015 |
Park JM, Wu T, Cyr AR, Woodfield GW, De Andrade JP, Spanheimer PM, Li T, Sugg SL, Lal G, Domann FE, Zhang W, Weigel RJ. The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis. Oncogene. PMID 25772240 DOI: 10.1038/Onc.2015.59 |
0.665 |
|
2015 |
Cyr AR, Kulak MV, Park JM, Bogachek MV, Spanheimer PM, Woodfield GW, White-Baer LS, O'Malley YQ, Sugg SL, Olivier AK, Zhang W, Domann FE, Weigel RJ. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis. Oncogene. 34: 436-44. PMID 24469049 DOI: 10.1038/Onc.2013.569 |
0.661 |
|
2014 |
Bogachek MV, Chen Y, Kulak MV, Woodfield GW, Cyr AR, Park JM, Spanheimer PM, Li Y, Li T, Weigel RJ. Sumoylation pathway is required to maintain the basal breast cancer subtype. Cancer Cell. 25: 748-61. PMID 24835590 DOI: 10.1016/J.Ccr.2014.04.008 |
0.525 |
|
2014 |
Spanheimer PM, Park JM, Askeland RW, Kulak MV, Woodfield GW, De Andrade JP, Cyr AR, Sugg SL, Thomas A, Weigel RJ. Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer Clinical Cancer Research. 20: 2115-2125. PMID 24526731 DOI: 10.1158/1078-0432.CCR-13-2221 |
0.352 |
|
2014 |
Spanheimer PM, Cyr AR, Gillum MP, Woodfield GW, Askeland RW, Weigel RJ. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy. Annals of Surgery. 259: 793-9. PMID 24045439 DOI: 10.1097/Sla.0B013E3182A6F552 |
0.409 |
|
2014 |
Park JM, Wu T, Woodfield G, Cyr A, Andrade JD, Zhang W, Domann F, Weigel RJ. Abstract 3914: Tcfap2c regulates growth and oncogenesis in neu-activated breast cancer Cancer Research. 74: 3914-3914. DOI: 10.1158/1538-7445.Am2014-3914 |
0.653 |
|
2014 |
Cyr AR, Kulak MV, Park JM, Bogachek MV, Spanheimer PM, Woodfield GW, White-Baer LS, O'Malley YQ, Sugg SL, Olivier AK, Zhang W, Domann FE, Weigel RJ. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis Oncogene. DOI: 10.1038/onc.2013.569 |
0.645 |
|
2013 |
Cyr AR, Brown KE, McCormick ML, Coleman MC, Case AJ, Watts GS, Futscher BW, Spitz DR, Domann FE. Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes. Redox Biology. 1: 172-7. PMID 24024150 DOI: 10.1016/J.Redox.2013.01.001 |
0.644 |
|
2013 |
Kulak MV, Cyr AR, Woodfield GW, Bogachek M, Spanheimer PM, Li T, Price DH, Domann FE, Weigel RJ. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer. Oncogene. 32: 4043-51. PMID 22964634 DOI: 10.1038/Onc.2012.400 |
0.671 |
|
2013 |
Cyr AR, Hitchler MJ, Domann FE. Regulation of SOD2 in cancer by histone modifications and CpG methylation: closing the loop between redox biology and epigenetics. Antioxidants & Redox Signaling. 18: 1946-55. PMID 22946823 DOI: 10.1089/Ars.2012.4850 |
0.67 |
|
2013 |
Spanheimer PM, Woodfield GW, Cyr AR, Kulak MV, White-Baer LS, Bair TB, Weigel RJ. Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor. Annals of Surgical Oncology. 20: 2204-12. PMID 22878616 DOI: 10.1245/S10434-012-2570-5 |
0.441 |
|
2013 |
Spanheimer P, Park JM, Askeland RW, Cyr AR, Woodfield GW, Weigel RJ. Vandetanib increases the efficacy of tamoxifen in a preclinical luminal breast cancer model Journal of the American College of Surgeons. 217. DOI: 10.1016/J.Jamcollsurg.2013.07.293 |
0.357 |
|
2012 |
Spanheimer PM, Woodfield GW, Cyr AR, Weigel RJ. TFAP2C regulates Erk1/2 activation and cell proliferation through the ret receptor in breast carcinoma Journal of the American College of Surgeons. 215. DOI: 10.1016/J.Jamcollsurg.2012.06.326 |
0.36 |
|
2011 |
Cyr AR, Domann FE. The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxidants & Redox Signaling. 15: 551-89. PMID 20919933 DOI: 10.1089/Ars.2010.3492 |
0.577 |
|
2010 |
Cyr AR, Case AJ, Mao G, Domann FE. Conditional Knockout of Sod2 in Murine Hepatocytes Disrupts Epigenetic Control of Gene Expression Free Radical Biology and Medicine. 49: S128. DOI: 10.1016/J.Freeradbiomed.2010.10.351 |
0.65 |
|
2010 |
Aykin-Burns N, Zhu Y, Cyr AR, Klingelhutz AJ, Domann FE. Exploring the Role of Cancer Cell Mitochondria in Malignant Phenotype Free Radical Biology and Medicine. 49: S54. DOI: 10.1016/J.Freeradbiomed.2010.10.121 |
0.617 |
|
Show low-probability matches. |